No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Positron emission tomography effective at assessing early tumor response to induction chemotherapy in esophageal or esophagogastric junction cancers

byTeddy Guo

December 12, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Dual therapy with infliximab and IVIG in children with multi-system inflammatory syndrome

RelatedReports

FDA-regulated clinical trials rarely report violations

The Scan by 2 Minute Medicine®

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

October 22, 2025

StudyGraphics

#VisualAbstract: Perioperative Durvalumab increased Survival in Gastric and Gastroesopha-geal Junction Cancer

August 7, 2025

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Chronic Disease

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

July 24, 2025

Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma

Chronic Disease

Relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer patients

July 23, 2025

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Recent trends in stroke severity, unfavourable outcomes, and mortality compared by sex

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

Treatment with clopidogrel with aspirin or ticagrelor with aspirin produces similar risk reduction of stroke recurrence or death

2 Minute Medicine Rewind October 21, 2019

Mental health apps improve well-being, mental health, and emotional regulation

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports